Related references
Note: Only part of the references are listed.Respiratory Syncytial Virus: Targeting the G Protein Provides a New Approach for an Old Problem
Ralph A. Tripp et al.
JOURNAL OF VIROLOGY (2018)
Structural basis for recognition of the central conserved region of RSV G by neutralizing human antibodies
Harrison G. Jones et al.
PLOS PATHOGENS (2018)
Structures of respiratory syncytial virus G antigen bound to broadly neutralizing antibodies
Stanislav O. Fedechkin et al.
SCIENCE IMMUNOLOGY (2018)
Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection
Cristina Capella et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells
B. Cortjens et al.
JOURNAL OF VIROLOGY (2017)
Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective
S. Boyoglu-Barnum et al.
JOURNAL OF VIROLOGY (2017)
Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines
Sandra Fuentes et al.
VACCINE (2017)
Animal models of respiratory syncytial virus infection
Geraldine Taylor
VACCINE (2017)
Preclinical evaluation of bacterially produced RSV-G protein vaccine: Strong protection against RSV challenge in cotton rat model
Sandra Fuentes et al.
SCIENTIFIC REPORTS (2017)
Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins
Sandra Fuentes et al.
PLOS PATHOGENS (2016)
CX3CR1 is an important surface molecule for respiratory syncytial virus infection in human airway epithelial cells
Tatiana Chirkova et al.
JOURNAL OF GENERAL VIROLOGY (2015)
Nonglycosylated G-Protein Vaccine Protects against Homologous and Heterologous Respiratory Syncytial Virus (RSV) Challenge, while Glycosylated G Enhances RSV Lung Pathology and Cytokine Levels
Sandra Fuentes et al.
JOURNAL OF VIROLOGY (2015)
Respiratory Syncytial Virus Uses CX3CR1 as a Receptor on Primary Human Airway Epithelial Cultures
Sara M. Johnson et al.
PLOS PATHOGENS (2015)
CX3CR1 Is Expressed in Differentiated Human Ciliated Airway Cells and Co-Localizes with Respiratory Syncytial Virus on Cilia in a G Protein-Dependent Manner
Kwang-Il Jeong et al.
PLOS ONE (2015)
Development of a simple, rapid, sensitive, high-throughput luciferase reporter based microneutralization test for measurement of virus neutralizing antibodies following Respiratory Syncytial Virus vaccination and infection
Sandra Fuentes et al.
VACCINE (2013)
Genetic Relatedness of Infecting and Reinfecting Respiratory Syncytial Virus Strains Identified in a Birth Cohort From Rural Kenya
Charles N. Agoti et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Genetic Variability among Complete Human Respiratory Syncytial Virus Subgroup A Genomes: Bridging Molecular Evolutionary Dynamics and Epidemiology
Lydia Tan et al.
PLOS ONE (2012)
Respiratory Syncytial Virus-associated Hospitalizations Among Infants and Young Children in the United States, 1997-2006
Lauren J. Stockman et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2012)
Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years
Peter L. Collins et al.
VIRUS RESEARCH (2011)
Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis
Harish Nair et al.
LANCET (2010)
Potent High-Affinity Antibodies for Treatment and Prophylaxis of Respiratory Syncytial Virus Derived from B Cells of Infected Patients
Ellen J. Collarini et al.
JOURNAL OF IMMUNOLOGY (2009)
Therapeutic Monoclonal Antibody Treatment Targeting Respiratory Syncytial Virus (RSV) G Protein Mediates Viral Clearance and Reduces the Pathogenesis of RSV Infection in BALB/c Mice
Lia M. Haynes et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Immune responses and disease enhancement during respiratory syncytial virus infection
PJM Openshaw et al.
CLINICAL MICROBIOLOGY REVIEWS (2005)
Human CD8+ T cell responses against five newly identified respiratory syncytial virus-derived epitopes
J Heidema et al.
JOURNAL OF GENERAL VIROLOGY (2004)
The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B
UF Power et al.
VACCINE (2003)
Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999
S Leader et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2002)
CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein
RA Tripp et al.
NATURE IMMUNOLOGY (2001)
Medical progress - Respiratory syncytial virus and parainfluenza virus.
CB Hall
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
